Therapeutic Asset Ratings

283 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
UREA, N-(2-CHLOROETHYL)-N'-(4-METHYLCYCLOHEXYL)-N-NITROSO- Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)	The First Affiliated Hospital of Soochow University	N/A	D (30)
Pomalidomide Follicular Lymphoma	The First Affiliated Hospital of Soochow University		D (28)
Cafizomide Plasma Cell Myeloma	The First Affiliated Hospital of Soochow University	N/A	D (26)
ct0594cp Plasma Cell Myeloma	The First Affiliated Hospital of Soochow University	N/A	D (26)
Sulpegfilgrastim Plasma Cell Myeloma	The First Affiliated Hospital of Soochow University	N/A	D (26)
U96 (lentiviral vector) B-Cell Neoplasm	The First Affiliated Hospital of Soochow University	P1	NR (0)
Sulpegfilgrastim Dystonia 5	The First Affiliated Hospital of Soochow University	N/A	NR (0)
Sulpegfilgrastim Sulpegfilgrastim	The First Affiliated Hospital of Soochow University	N/A	NR (0)

Showing 276 to 283 of 283 assets

PreviousPage 12 of 12Next